203 related articles for article (PubMed ID: 22532389)
1. Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice.
Glund S; Schoelch C; Thomas L; Niessen HG; Stiller D; Roth GJ; Neubauer H
Diabetologia; 2012 Jul; 55(7):2044-53. PubMed ID: 22532389
[TBL] [Abstract][Full Text] [Related]
2. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice.
O'Neill HM; Lally JS; Galic S; Thomas M; Azizi PD; Fullerton MD; Smith BK; Pulinilkunnil T; Chen Z; Samaan MC; Jorgensen SB; Dyck JR; Holloway GP; Hawke TJ; van Denderen BJ; Kemp BE; Steinberg GR
Diabetologia; 2014 Aug; 57(8):1693-702. PubMed ID: 24913514
[TBL] [Abstract][Full Text] [Related]
3. ACC2 Deletion Enhances IMCL Reduction Along With Acetyl-CoA Metabolism and Improves Insulin Sensitivity in Male Mice.
Takagi H; Ikehara T; Kashiwagi Y; Hashimoto K; Nanchi I; Shimazaki A; Nambu H; Yukioka H
Endocrinology; 2018 Aug; 159(8):3007-3019. PubMed ID: 29931154
[TBL] [Abstract][Full Text] [Related]
4. A Novel Acetyl-CoA Carboxylase 2 Selective Inhibitor Improves Whole-Body Insulin Resistance and Hyperglycemia in Diabetic Mice through Target-Dependent Pathways.
Takagi H; Tanimoto K; Shimazaki A; Tonomura Y; Momosaki S; Sakamoto S; Abe K; Notoya M; Yukioka H
J Pharmacol Exp Ther; 2020 Mar; 372(3):256-263. PubMed ID: 31900320
[TBL] [Abstract][Full Text] [Related]
5. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
Takagi H; Ikehara T; Hashimoto K; Tanimoto K; Shimazaki A; Kashiwagi Y; Sakamoto S; Yukioka H
Eur J Pharmacol; 2021 Nov; 910():174451. PubMed ID: 34454928
[TBL] [Abstract][Full Text] [Related]
7. Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects.
Rosa G; Manco M; Vega N; Greco AV; Castagneto M; Vidal H; Mingrone G
Obes Res; 2003 Nov; 11(11):1306-12. PubMed ID: 14627750
[TBL] [Abstract][Full Text] [Related]
8. Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake.
Olson DP; Pulinilkunnil T; Cline GW; Shulman GI; Lowell BB
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7598-603. PubMed ID: 20368432
[TBL] [Abstract][Full Text] [Related]
9. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
10. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
[TBL] [Abstract][Full Text] [Related]
11. Minimal impact of age and housing temperature on the metabolic phenotype of Acc2-/- mice.
Brandon AE; Stuart E; Leslie SJ; Hoehn KL; James DE; Kraegen EW; Turner N; Cooney GJ
J Endocrinol; 2016 Mar; 228(3):127-34. PubMed ID: 26668208
[TBL] [Abstract][Full Text] [Related]
12. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
13. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets.
Abu-Elheiga L; Oh W; Kordari P; Wakil SJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10207-12. PubMed ID: 12920182
[TBL] [Abstract][Full Text] [Related]
15. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity.
Beck Jørgensen S; O'Neill HM; Hewitt K; Kemp BE; Steinberg GR
Diabetologia; 2009 Nov; 52(11):2395-404. PubMed ID: 19688337
[TBL] [Abstract][Full Text] [Related]
16. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
Abu-Elheiga L; Matzuk MM; Kordari P; Oh W; Shaikenov T; Gu Z; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12011-6. PubMed ID: 16103361
[TBL] [Abstract][Full Text] [Related]
17. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice.
Oh W; Abu-Elheiga L; Kordari P; Gu Z; Shaikenov T; Chirala SS; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1384-9. PubMed ID: 15677334
[TBL] [Abstract][Full Text] [Related]
18. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
19. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity.
Choi CS; Savage DB; Abu-Elheiga L; Liu ZX; Kim S; Kulkarni A; Distefano A; Hwang YJ; Reznick RM; Codella R; Zhang D; Cline GW; Wakil SJ; Shulman GI
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16480-5. PubMed ID: 17923673
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.
Båvenholm PN; Pigon J; Saha AK; Ruderman NB; Efendic S
Diabetes; 2000 Jul; 49(7):1078-83. PubMed ID: 10909961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
